ITLN1 and cancer: Importantly, a case–control study conducted on 40 patients with PCa and 40 patients with BPH, reported significantly elevated concentrations of omentin in patients with cancer, leading the authors to propose the use of this adipokine as a noninvasive biomarker of PCa [244].